2014 -- S 2359 | |
======== | |
LC004580 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - HEALTH CARE SERVICES - UTILIZATION | |
REVIEW ACT | |
| |
Introduced By: Senators Miller, Cool Rumsey, Ottiano, Sosnowski, and Goldin | |
Date Introduced: February 12, 2014 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 23-17.12-9 of the General Laws in Chapter 23-17.12 entitled |
2 | "Health Care Services - Utilization Review Act" is hereby amended to read as follows: |
3 | 23-17.12-9. Review agency requirement for adverse determination and internal |
4 | appeals. -- (a) The adverse determination and appeals process of the review agent shall conform |
5 | to the following: |
6 | (1) Notification of a prospective adverse determination by the review agent shall be |
7 | mailed or otherwise communicated to the provider of record and to the patient or other |
8 | appropriate individual as follows: |
9 | (i) Within fifteen (15) business days of receipt of all the information necessary to |
10 | complete a review of non-urgent and/or non-emergent services; |
11 | (ii) Within seventy-two (72) hours of receipt of all the information necessary to complete |
12 | a review of urgent and/or emergent services; and |
13 | (iii) Make all determinations on whether to authorize or certify an emergency inpatient |
14 | admission or an admission for residential crisis services for treatment of a mental, emotional, or |
15 | substance abuse disorder within two (2) hours after receipt of the necessary information. If a |
16 | private review agent makes an initial determination not to authorize a health care service, the law |
17 | provides a process for a health care provider to seek reconsideration; and |
18 | (iii) (iv) Prior to the expected date of service. |
| |
1 | (2) Notification of a concurrent adverse determination shall be mailed or otherwise |
2 | communicated to the patient and to the provider of record period as follows: |
3 | (i) To the provider(s) prior to the end of the current certified period; and |
4 | (ii) To the patient within one business day of making the adverse determination. |
5 | (3) Notification of a retrospective adverse determination shall be mailed or otherwise |
6 | communicated to the patient and to the provider of record within thirty (30) business days of |
7 | receipt of a request for payment with all supporting documentation for the covered benefit being |
8 | reviewed. |
9 | (4) A utilization review agency shall not retrospectively deny authorization for health |
10 | care services provided to a covered person when an authorization has been obtained for that |
11 | service from the review agent unless the approval was based upon inaccurate information |
12 | material to the review or the health care services were not provided consistent with the provider's |
13 | submitted plan of care and/or any restrictions included in the prior approval granted by the review |
14 | agent. |
15 | (5) Any notice of an adverse determination shall include: |
16 | (i) The principal reasons for the adverse determination, to include explicit documentation |
17 | of the criteria not met and/or the clinical rationale utilized by the agency's clinical reviewer in |
18 | making the adverse determination. The criteria shall be in accordance with the agency criteria |
19 | noted in subsection 23-17.12-9(d) and shall be made available within the first level appeal |
20 | timeframe if requested unless otherwise provided as part of the adverse determination notification |
21 | process; |
22 | (ii) The procedures to initiate an appeal of the adverse determination, including the name |
23 | and telephone number of the person to contract with regard to an appeal; |
24 | (iii) The necessary contact information to complete the two-way direct communication |
25 | defined in subdivision 23-17.12-9(a)(7); and |
26 | (iv) The information noted in subdivision 23-27.12-9(a)(5)(i)(ii)(iii) for all verbal |
27 | notifications followed by written notification to the patient and provider(s). |
28 | (6) All initial retrospective adverse determinations of a health care service that had been |
29 | ordered by a physician, dentist or other practitioner shall be made, documented and signed |
30 | consistent with the regulatory requirements which shall be developed by the department with the |
31 | input of review agents, providers and other affected parties. |
32 | (7) A level one appeal decision of an adverse determination shall not be made until an |
33 | appropriately qualified and licensed review physician, dentist or other practitioner has spoken to, |
34 | or otherwise provided for, an equivalent two-way direct communication with the patient's |
| LC004580 - Page 2 of 7 |
1 | attending physician, dentist, other practitioner, other designated or qualified professional or |
2 | provider responsible for treatment of the patient concerning the medical care, with the exception |
3 | of the following: |
4 | (i) When the attending provider is not reasonably available; |
5 | (ii) When the attending provider chooses not to speak with agency staff; |
6 | (iii) When the attending provider has negotiated an agreement with the review agent for |
7 | alternative care; and/or |
8 | (iv) When the attending provider requests a peer to peer communication prior to the |
9 | adverse determination, the review agency shall then comply with subdivision 23-17.12-9(c)(1) in |
10 | responding to such a request. Such requests shall be on the case specific basis unless otherwise |
11 | arranged for in advance by the provider. |
12 | (8) All initial, prospective and concurrent adverse determinations of a health care service |
13 | that had been ordered by a physician, dentist or other practitioner shall be made, documented and |
14 | signed by a licensed practitioner with the same licensure status as the ordering practitioner or a |
15 | licensed physician or dentist. This does not prohibit appropriately qualified review agency staff |
16 | from engaging in discussions with the attending provider, the attending provider's designee or |
17 | appropriate health care facility and office personnel regarding alternative service and treatment |
18 | options. Such a discussion shall not constitute an adverse determination provided though that any |
19 | change to the provider's original order and/or any decision for an alternative level of care must be |
20 | made and/or appropriately consented to by the attending provider or the provider's designee |
21 | responsible for treating the patient. |
22 | (9) The requirement that, upon written request made by or on behalf of a patient, any |
23 | adverse determination and/or appeal shall include the written evaluation and findings of the |
24 | reviewing physician, dentist or other practitioner. The review agent is required to accept a verbal |
25 | request made by or on behalf of a patient for any information where a provider or patient can |
26 | demonstrate that a timely response is urgent. |
27 | (b) The review agent shall conform to the following for the appeal of an adverse |
28 | determination: |
29 | (1) The review agent shall maintain and make available a written description of the |
30 | appeal procedure by which either the patient or the provider of record may seek review of |
31 | determinations not to authorize a health care service. The process established by each review |
32 | agent may include a reasonable period within which an appeal must be filed to be considered and |
33 | that period shall not be less than sixty (60) days. |
34 | (2) The review agent shall notify, in writing, the patient and provider of record of its |
| LC004580 - Page 3 of 7 |
1 | decision on the appeal as soon as practical, but in no case later than fifteen (15) or twenty-one |
2 | (21) business days if verbal notice is given within fifteen (15) business days after receiving the |
3 | required documentation on the appeal. |
4 | (3) The review agent shall also provide for an expedited appeals process for emergency |
5 | or life threatening situations. Each review agent shall complete the adjudication of expedited |
6 | appeals within two (2) business days of the date the appeal is filed and all information necessary |
7 | to complete the appeal is received by the review agent. |
8 | (4) All first level appeals of determinations not to authorize a health care service that had |
9 | been ordered by a physician, dentist, or other practitioner shall be made, documented, and signed |
10 | by a licensed practitioner with the same licensure status as the ordering practitioner or a licensed |
11 | physician or a licensed dentist. |
12 | (5) All second level appeal decisions shall be made, signed, and documented by a |
13 | licensed practitioner in the same or a similar general specialty as typically manages the medical |
14 | condition, procedure, or treatment under discussion. |
15 | (6) The review agent shall maintain records of written appeals and their resolution, and |
16 | shall provide reports as requested by the department. |
17 | (c) The review agency must conform to the following requirements when making its |
18 | adverse determination and appeal decisions: |
19 | (1) The review agent must assure that the licensed practitioner or licensed physician is |
20 | reasonably available to review the case as required under subdivision 23-17.12-9(a)(7) and shall |
21 | conform to the following: |
22 | (i) Each agency peer reviewer shall have access to and review all necessary information |
23 | as requested by the agency and/or submitted by the provider(s) and/or patients; |
24 | (ii) Each agency shall provide accurate peer review contact information to the provider at |
25 | the time of service, if requested, and/or prior to such service, if requested. This contact |
26 | information must provide a mechanism for direct communication with the agency's peer |
27 | reviewer; |
28 | (iii) Agency peer reviewers shall respond to the provider's request for a two-way direct |
29 | communication defined in subdivision 23-17.12-9(a)(7)(iv) as follows: |
30 | (A) For a prospective review of non-urgent and non-emergent health care services, a |
31 | response within one business day of the request for a peer discussion; |
32 | (B) For concurrent and prospective reviews of urgent and emergent health care services, |
33 | a response within a reasonable period of time of the request for a peer discussion; and |
34 | (C) For retrospective reviews, prior to the first level appeal decision. |
| LC004580 - Page 4 of 7 |
1 | (iv) The review agency will have met the requirements of a two-way direct |
2 | communication, when requested and/or as required prior to the first level of appeal, when it has |
3 | made two (2) reasonable attempts to contact the attending provider directly. |
4 | (v) Repeated violations of this section shall be deemed to be substantial violations |
5 | pursuant to section 23-17.12-14 and shall be cause for the imposition of penalties under that |
6 | section. |
7 | (2) No reviewer at any level under this section shall be compensated or paid a bonus or |
8 | incentive based on making or upholding an adverse determination. |
9 | (3) No reviewer under this section who has been involved in prior reviews of the case |
10 | under appeal or who has participated in the direct care of the patient may participate as the sole |
11 | reviewer in reviewing a case under appeal; provided, however, that when new information has |
12 | been made available at the first level of appeal, then the review may be conducted by the same |
13 | reviewer who made the initial adverse determination. |
14 | (4) A review agent is only entitled to review information or data relevant to the |
15 | utilization review process. A review agent may not disclose or publish individual medical records |
16 | or any confidential medical information obtained in the performance of utilization review |
17 | activities. A review agent shall be considered a third party health insurer for the purposes of |
18 | section 5-37.3-6(b)(6) of this state and shall be required to maintain the security procedures |
19 | mandated in section 5-37.3-4(c). |
20 | (5) Notwithstanding any other provision of law, the review agent, the department, and all |
21 | other parties privy to information which is the subject of this chapter shall comply with all state |
22 | and federal confidentiality laws, including, but not limited to, chapter 37.3 of title 5 |
23 | (Confidentiality of Health Care Communications and Information Act) and specifically section 5- |
24 | 37.3-4(c), which requires limitation on the distribution of information which is the subject of this |
25 | chapter on a "need to know" basis, and section 40.1-5-26. |
26 | (6) The department may, in response to a complaint that is provided in written form to |
27 | the review agent, review an appeal regarding any adverse determination, and may request |
28 | information of the review agent, provider or patient regarding the status, outcome or rationale |
29 | regarding the decision. |
30 | (d) The requirement that each review agent shall utilize and provide upon request, by |
31 | Rhode Island licensed hospitals and the Rhode Island Medical Society, in either electronic or |
32 | paper format, written medically acceptable screening criteria and review procedures which are |
33 | established and periodically evaluated and updated with appropriate consultation with Rhode |
34 | Island licensed physicians, hospitals, including practicing physicians, and other health care |
| LC004580 - Page 5 of 7 |
1 | providers in the same specialty as would typically treat the services subject to the criteria as |
2 | follows: |
3 | (1) Utilization review agents shall consult with no fewer than five (5) Rhode Island |
4 | licensed physicians or other health care providers. Further, in instances where the screening |
5 | criteria and review procedures are applicable to inpatients and/or outpatients of hospitals, the |
6 | medical director of each licensed hospital in Rhode Island shall also be consulted. Utilization |
7 | review agents who utilize screening criteria and review procedures provided by another entity |
8 | may satisfy the requirements of this section if the utilization review agent demonstrates to the |
9 | satisfaction of the director that the entity furnishing the screening criteria and review procedures |
10 | has complied with the requirements of this section. |
11 | (2) Utilization review agents seeking initial certification shall conduct the consultation |
12 | for all screening and review criteria to be utilized. Utilization review agents who have been |
13 | certified for one year or longer shall be required to conduct the consultation on a periodic basis |
14 | for the utilization review agent's highest volume services subject to utilization review during the |
15 | prior year; services subject to the highest volume of adverse determinations during the prior year; |
16 | and for any additional services identified by the director. |
17 | (3) Utilization review agents shall not include in the consultations as required under |
18 | paragraph (1) of this subdivision, any physicians or other health services providers who have |
19 | financial relationships with the utilization review agent other than financial relationships for |
20 | provisions of direct patient care to utilization review agent enrollees and reasonable compensation |
21 | for consultation as required by paragraph (1) of this subdivision. |
22 | (4) All documentation regarding required consultations, including comments and/or |
23 | recommendations provided by the health care providers involved in the review of the screening |
24 | criteria, as well as the utilization review agent's action plan or comments on any |
25 | recommendations, shall be in writing and shall be furnished to the department on request. The |
26 | documentation shall also be provided on request to any licensed health care provider at a nominal |
27 | cost that is sufficient to cover the utilization review agent's reasonable costs of copying and |
28 | mailing. |
29 | (5) Utilization review agents may utilize non-Rhode Island licensed physicians or other |
30 | health care providers to provide the consultation as required under paragraph (1) of this |
31 | subdivision, when the utilization review agent can demonstrate to the satisfaction of the director |
32 | that the related services are not currently provided in Rhode Island or that another substantial |
33 | reason requires such approach. |
34 | (6) Utilization review agents whose annualized data reported to the department |
| LC004580 - Page 6 of 7 |
1 | demonstrate that the utilization review agent will review fewer than five hundred (500) such |
2 | requests for authorization may request a variance from the requirements of this section. |
3 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC004580 | |
======== | |
| LC004580 - Page 7 of 7 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - HEALTH CARE SERVICES - UTILIZATION | |
REVIEW ACT | |
*** | |
1 | This act would authorize a utilization review agent to determine whether to authorize or |
2 | certify emergency inpatient admissions or admission for residential crisis service treatment of a |
3 | mental, emotional, or substance abuse disorder within two (2) hours of receipt of the necessary |
4 | information. |
5 | This act would take effect upon passage. |
======== | |
LC004580 | |
======== | |
| LC004580 - Page 8 of 7 |